Ginkgo Bioworks Holdings, Inc. officer Che Austin is set to sell 3,968 Class A shares of the company on 04/08/2024, as per the latest filing. These shares, valued at an aggregate market value of $4,245.76, were originally acquired on 10/07/2022 as part of a restricted stock vesting and were compensation for services rendered to the issuer. This upcoming transaction follows a series of sales over the past three months, where a total of 246,016 shares were sold for gross proceeds of approximately $309,900.80. The notice for the planned sale was filed on the same date as the sale, with the plan for this transaction having been adopted on 03/14/2023.

Ginkgo Bioworks Holdings, Inc. officer Che Austin is set to sell 3,968 Class A shares of the company on 04/08/2024, as per the latest filing. These shares, valued at an aggregate market value of $4,245.76, were originally acquired on 10/07/2022 as part of a restricted stock vesting and were compensation for services rendered to the issuer. This upcoming transaction follows a series of sales over the past three months, where a total of 246,016 shares were sold for gross proceeds of approximately $309,900.80. The notice for the planned sale was filed on the same date as the sale, with the plan for this transaction having been adopted on 03/14/2023.